CN104491585A - 风湿性关节炎祛风胜湿膏及制备方法 - Google Patents
风湿性关节炎祛风胜湿膏及制备方法 Download PDFInfo
- Publication number
- CN104491585A CN104491585A CN201510003783.3A CN201510003783A CN104491585A CN 104491585 A CN104491585 A CN 104491585A CN 201510003783 A CN201510003783 A CN 201510003783A CN 104491585 A CN104491585 A CN 104491585A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- rheumatic arthritis
- expelling wind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000003068 rheumatic fever Diseases 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 230000000694 effects Effects 0.000 title abstract description 22
- 210000000941 bile Anatomy 0.000 claims abstract description 34
- 241001517312 Calanthe Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 16
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims description 53
- 239000006071 cream Substances 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000012567 medical material Substances 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000004745 nonwoven fabric Substances 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 241000282894 Sus scrofa domesticus Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 3
- 238000011282 treatment Methods 0.000 abstract description 17
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 244000241838 Lycium barbarum Species 0.000 abstract description 3
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 3
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 2
- 241000218993 Begonia Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000208371 Euonymus maackii Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000967218 Selaginella tamariscina Species 0.000 abstract 1
- 241000991004 Streptocaulon Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 31
- 230000036407 pain Effects 0.000 description 29
- 230000008961 swelling Effects 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 208000006820 Arthralgia Diseases 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 8
- 206010003246 arthritis Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 239000011505 plaster Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010040952 Skin warm Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- 238000004062 sedimentation Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 210000004247 hand Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000002040 relaxant effect Effects 0.000 description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 description 4
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010041290 Soft tissue inflammation Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010322 bone marrow transplantation Methods 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229960000905 indomethacin Drugs 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 2
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241001254604 Angelica pubescens Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000903946 Clematidis Species 0.000 description 2
- -1 Coumarins compound Chemical class 0.000 description 2
- 241000125183 Crithmum maritimum Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 210000001513 elbow Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- XVARCVCWNFACQC-RKQHYHRCSA-N indican Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=CC=C12 XVARCVCWNFACQC-RKQHYHRCSA-N 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229960001639 penicillamine Drugs 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000317412 Arisaema amurense Species 0.000 description 1
- 241000317400 Arisaema heterophyllum Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241001390755 Begonia pedatifida Species 0.000 description 1
- 241000218999 Begoniaceae Species 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 241000269417 Bufo Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- GQEVCHQXWPWARL-UHFFFAOYSA-N Couroupitine A Natural products N1=CC=CC2=CC(=O)N3C4=CC=CC=C4C(=O)C3=C21 GQEVCHQXWPWARL-UHFFFAOYSA-N 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- BAHUBXAYVOCLNA-UHFFFAOYSA-N Isoangelol Natural products O1C(=O)C=CC2=C1C=C(OC)C(C(OC(=O)C(C)=CC)C(O)C(C)(C)O)=C2 BAHUBXAYVOCLNA-UHFFFAOYSA-N 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 241000218978 Populus deltoides Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241001604597 Pyrestini Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- 241000195974 Selaginella Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- BAHUBXAYVOCLNA-OEQDPHDDSA-N [(1r,2r)-2,3-dihydroxy-1-(7-methoxy-2-oxochromen-6-yl)-3-methylbutyl] (e)-2-methylbut-2-enoate Chemical compound O1C(=O)C=CC2=C1C=C(OC)C([C@@H](OC(=O)C(\C)=C\C)[C@@H](O)C(C)(C)O)=C2 BAHUBXAYVOCLNA-OEQDPHDDSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 description 1
- 229960003099 amcinonide Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- JRIBPWOXWIRQOQ-GHAIFCDISA-N columbianadin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(C)OC(=O)C(\C)=C/C)O1 JRIBPWOXWIRQOQ-GHAIFCDISA-N 0.000 description 1
- XACHIBLJLSNFHL-UHFFFAOYSA-N columbianadin Natural products CC=C(C)/C(=O)OC(C)(C)C1CC2=C(O1)C=CC3C=CC(=O)OC23 XACHIBLJLSNFHL-UHFFFAOYSA-N 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- XXPBFNVKTVJZKF-UHFFFAOYSA-N dihydrophenanthrene Natural products C1=CC=C2CCC3=CC=CC=C3C2=C1 XXPBFNVKTVJZKF-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- BXFFHSIDQOFMLE-UHFFFAOYSA-N indoxyl sulfate Natural products C1=CC=C2C(OS(=O)(=O)O)=CNC2=C1 BXFFHSIDQOFMLE-UHFFFAOYSA-N 0.000 description 1
- XVARCVCWNFACQC-UHFFFAOYSA-N indoxyl-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CNC2=CC=CC=C12 XVARCVCWNFACQC-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000007896 modified release capsule Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001792 phenanthrenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000003156 vasculitic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种风湿性关节炎祛风胜湿膏及其制备方法,取下述重量配比的主要原料药制备而成:独活10-20,丝棉木6-12,红孩儿9-12,葛根20-30,川芎9-16,薏米10-20,川断9-18,小过江龙8-15,天南星(胆汁制)9-12,古羊藤12-16,牛蒡子15-25,枸杞子20-30,九子连环草10-15。本发明提供的风湿性关节炎祛风胜湿膏治疗成本低、无副作用、无创伤、疗效显著、不易复发。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种风湿性关节炎祛风胜湿膏及其制备方法。
背景技术
风湿性关节炎是一种常见的急性或慢性结缔组织炎症,可反复发作并累及心脏。临床以关节和肌肉游走性酸楚、重著、疼痛为特征,属变态反应性疾病。它是风湿热的主要表现之一,多以急性发热及关节疼痛起病。典型表现是轻度或中度发热,游走性多关节炎,受累关节多为膝、踝、肩、肘、腕等大关节,常见由一个关节转移至另一个关节,病变局部呈现红、肿、灼热、剧痛,部分病人也有几个关节同时发病。不典型的病人仅有关节疼痛而无其他炎症表现,急性炎症一般于2~4周消退,不留后遗症,但常反复发作。若风湿活动影响心脏,则可发生心肌炎,甚至遗留心脏瓣膜病变。风湿性关节炎的病因尚未完全明了。根据症状、流行病学及免疫学的资计分析,认为与人体溶血性链球菌感染密切相关,目前注意到病毒感染与本病也有一定关系。
风湿性关节炎的治疗:1.药物治疗。治疗原则是早期诊断和尽早合理、联合用药。常用的抗风湿病药物如下:(1)非淄体抗炎药:可抑制前列腺素的合成而迅速产生抗炎止痛作用,对解除疼痛有较好效果,但不能改变疾病的病程。临床上常用的有盐酸氨基葡萄糖颗粒、布洛芬、青霉胺、双氯酚酸、阿司匹林、吲哚美辛等。(2)慢作用抗风湿药:多用于类风湿关节炎及血清阴性脊柱关节病。对病情有一定控制作用但起效较慢。常用的有金合剂(肌注或口服)、青霉胺、柳氮磺胺吡啶、氯喹等。(3)细胞毒药物:通过不同途径产生免疫抑制作用。常用的有环磷酰胺、甲氨蝶呤、金独春等。它们往往是系统性红斑狼疮、类风湿关节炎和血管炎的二线药物,副作用虽较多且较严重,但对改善这些疾病的愈后有很大的作用。(4)肾上腺皮质激素是抗炎、抗过敏药物,明显地改善了系统性红斑狼疮等结缔组织病的愈后,但不能根治这些疾病。其众多的副作用随剂量加大及疗程延长而增加,故在应用时要衡量它的疗效和副作用而慎重选用。2.外科疗法。包括不同的矫形手术、人工关节的置换、滑膜切除等。手术不能治愈疾病只能改善关节功能和生活的能力。3.骨髓移植治疗风湿性关节炎确实有显著的疗效。通过恢复免疫系统功能来促使患者痊愈的自身骨髓移植法,治疗儿童风湿性关节炎取得了较好的疗效。骨髓移植的具体步骤是:先抽出患者身上的骨髓,用药物和放射等手段对骨髓进行处理,除其中的T细胞,再把处理过的骨髓注射回患者体内,并使用特殊药物促使患者骨髓生长,使患者免疫系统功能恢复正常。可以使患者在几年内不再发病,对于处于骨架和关节生长期的儿童非常重要。4.其他治疗。包括物理、康复、职业训练、心理等治疗,是本类疾病综合治疗的不可少的部分。
申请公布号 CN 102743545 A(申请号 201210186089.6)的中国专利文献公开了一种治疗风湿性关节炎的中药膏,其各原料组分的重量配比为:麻黄8-12、桂枝13-17、细辛8-12、蒿本13-17、威灵仙13-17、徐长卿13-17、两面针28-32、当归13-17、川芎8-12、羌活8-12、白芷8-12、草乌6-10、马钱子1-5、穿山龙1-5、海风藤4-8。申请公布号 CN 102813867 A(申请号 201210297416.5)的中国专利文献公开了一种治疗风湿性关节炎的中药膏贴,是由以下中药原料制成,秦艽、小红参、茯神、蛇床子、桑枝、远志、马钱子、乌蛇、全蝎、白芥子、山柰、木鳖子、藤黄、血竭、花椒、蟾蜍、地肤子、无名异、荜茇、一枝蒿、乌梅、桂枝、威灵仙、丝瓜藤、羌活、麻黄、络石藤、独活、海风藤、海桐皮、伸筋草、覆盆子、穿山龙、巴豆、刘寄奴、透骨草、自然铜、麝香、芡实、蜈蚣。申请公布号 CN 103330794 A(申请号 201310219614.4)的中国专利文献公开了一种治疗风湿性关节炎的药膏,它是由下述重量份的原料组成的:麻黄20-30、银杏根20-30、延胡索10-20、川牛膝10-20、独活10-12、淫羊藿10-20、地枫皮15-20、续断10-15、青风藤8-10、熟地10-14、仙茅6-10、羌活10-18、川穹10-13、白术7-10、制马钱子20-30、土元10-15、徐长卿10-20、黄芪10-20、五倍子10-20、无爷藤6-10、松节8-10。
风湿性关节炎患者常常被关节痛所折磨,而且,还因关节痛使得生活质量下降。西医主要采用镇痛消炎药、激素类药等来控制症状、稳定病情,可是所用药物大多副作用严重,使不少病人望而生畏。迄今为止,并没有发现一种特效药物可以防止或显著减慢关节结构破坏的进程。而手术治疗,由于适应症要求非常严格,临床上适合做手术的人群不足5%,而且存在费用高,创伤大,恢复期长,易复发等特点,所以根本无法全面推广这种风湿性关节炎的治疗方法。
发明内容
针对现有技术的不足,本发明的目的是提供一种风湿性关节炎祛风胜湿膏及其制备方法。本发明提供的风湿性关节炎祛风胜湿膏治疗成本低、无副作用、无创伤、疗效显著、不易复发。
本发明的技术方案是:
风湿性关节炎祛风胜湿膏,取下述重量配比的主要原料药制备而成:独活10-20,丝棉木6-12,红孩儿9-12,葛根20-30,川芎9-16,薏米10-20,川断9-18,小过江龙8-15,天南星(胆汁制)9-12,古羊藤12-16,牛蒡子15-25,枸杞子20-30,九子连环草10-15。
风湿性关节炎祛风胜湿膏,优选的方案是,取下述重量配比的主要原料药制备而成:独活13-17,丝棉木8-11,红孩儿9.5-11,葛根22-27,川芎12-15,薏米14-18,川断11-15,小过江龙10-13,天南星(胆汁制)9.5-11,古羊藤13-15,牛蒡子19-22,枸杞子22-26,九子连环草11-13。
风湿性关节炎祛风胜湿膏,更加优选的方案是,取下述重量配比的主要原料药制备而成:独活15,丝棉木10,红孩儿10,葛根25,川芎14,薏米16,川断14,小过江龙12,天南星(胆汁制)10.5,古羊藤14,牛蒡子20,枸杞子24,九子连环草12。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐1.8-2.5kg(优选的,每100kg红孩儿用食盐2.0-2.3kg;更加优选的,每100kg红孩儿用食盐2.2kg),闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入胆汁(优选的,加入的胆汁为猪胆汁、牛胆汁或羊胆汁;更加优选的,加入的胆汁为牛胆汁),每100kg天南星加胆汁250-500kg(优选的,每100kg天南星加胆汁300-450kg;更加优选的,每100kg天南星加胆汁400kg),至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的7-10倍(优选的,第一次加水量为11味药材总重量的8-9.5倍;更加优选的,第一次加水量为11味药材总重量的8.8倍),先用大火煮至沸腾,后转小火煎煮1.4-2小时(优选的,后转小火煎煮1.5-1.8小时;更加优选的,后转小火煎煮1.6小时),第二次加水量为11味药材总重量的5.5-8.5倍(优选的,第二次加水量为11味药材总重量的6.5-7.5倍;更加优选的,第二次加水量为11味药材总重量的7倍),先用大火煮至沸腾,后转小火煎煮1.1-1.6小时(优选的,后转小火煎煮1.2-1.5小时;更加优选的,后转小火煎煮1.4小时),滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的1.8-2.8倍(优选的,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.2-2.6倍;更加优选的,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.4倍),加入乙醇,使乙醇量达50%-70%(优选的,使乙醇量达55%-65%;更加优选的,使乙醇量达60%),静置24 h,取上清液,浓缩至相对密度为1.05-1.15的流浸膏(优选的,浓缩至相对密度为1.08-1.13的流浸膏;更加优选的,浓缩至相对密度为1.1的流浸膏),然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
本发明提供的风湿性关节炎祛风胜湿膏制备方法简单,所得产品使用方便、便于携带。除此之外,本发明的优良效果还表现在:
1、由多味纯中草药精细配伍而成,使用膏药外治法,针对性给药,使药效得到充分吸收,从而实现祛风除湿、调肝益肾、舒筋活络、通痹止痛、通利关节等功效,达到治愈风湿性关节炎的目的;
2、治疗成本低,减轻患者的经济负担;
3、疗效显著、无创伤、无副作用,减轻患者的痛苦;
4、标本同治,不易复发。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
本发明所用主要中药原料的药理如下:
独活:基原:为伞形科植物重齿毛当归的干燥根。化学成分:根中有苦士香豆精类化合物,二氢山芹醇及其已酸酯,欧芹酚甲醚,异欧前胡内酯,香柑内酯,花椒毒素,二氢山芹醇当归酸酯,二氢山芹醇葡萄糖甙,毛当归醇,当归醇D、G、B。还含γ-氨基丁酸及挥发油。药性:辛、苦,微温。归肾、膀胱经。功用主治:祛风除湿,通痹止痛。用于风寒湿痹,腰膝疼痛,少阴伏风头痛。
丝棉木:基原:为卫矛科植物丝棉木的根、树皮。药性:苦、辛,凉。归肝、脾、肾经。功用主治:祛风除湿,活血通络,解毒止血。主风湿性关节炎,腰痛,跌打伤肿,血栓闭塞性脉管炎,肺痈,衄血,疖疮肿毒。
红孩儿:基原:为秋海棠科植物裂叶秋海棠的全草。药性:甘、酸,寒。功用主治:清热解毒,散瘀消肿。主肺热咳嗽,疔疮痈肿,痛经,闭经,风湿热痹,跌打肿痛,蛇蛟伤。
葛根:基原:为豆科植物野葛的干燥根。习称野葛。干燥。药性:甘、辛,凉。归脾、胃经。功用主治:解肌退热,生津,透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻,高血压颈项强痛。
川芎:基原:为伞形科植物川穹的干燥根茎。药性:辛,温。归肝、胆、心包经。功用主治:活血行气,祛风止痛。用于月经不调,经闭痛经,癥瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
薏米:又名薏苡仁、苡仁、六谷子,基原:为禾本科植物薏苡的种仁。药性:甘淡、微寒、无毒。归脾、胃、肺、大肠经。功用主治:清热利湿,除风湿,利小便,益肺排脓,健脾胃,强筋骨。主治风湿身痛,湿热脚气,湿热筋急拘挛,湿痹,水肿,肺萎肺痈,咳吐脓血,喉痹痈肿,肠痈热淋。
川断:基原:为多年生草本植物川续断的根。药性:苦辛,微温。归肝、肾经。功用主治:补肝肾,续筋骨,调血脉。治腰背酸痛,足膝无力,胎漏,崩漏,带下,遗精,跌打损伤,金疮,痔漏,痈疽疮肿。
小过江龙:基原:为卷柏科植物蔓生卷柏的全草。药性:苦、微辛,微寒。功用主治:清热利湿,舒筋活络。主治肝炎,腹泻,风湿性关节炎,烫伤,外伤出血。
天南星:基原:为天南星科植物天南星、东北天南星或异叶天南星等的块茎。化学成份:含β-谷甾醇-D-葡萄糖甙及氨基酸。药理作用:天南星具有抗肿瘤作用。药性:苦、辛,温,有毒。归肺、肝、脾经。功用主治:燥湿化痰,祛风定惊,消肿散结。治中风痰塑,口眼歪斜,半身不遂,癫痫,惊风,破伤风,风痰眩晕,喉痹,瘰疬,痈肿,跌扑折伤,蛇虫咬伤。天南星(胆汁制)为天南星与动物胆汁的加工品。
古羊藤:基原:为双子叶植物药萝藦科植物马连鞍的根。药性:苦、微甘,凉。归脾、肾、膀胱经。功用主治:清热解毒,散瘀止痛。用于感冒发热,痢疾,胃痛,腹痛,跌打瘀痛,毒蛇咬伤。
牛蒡子:基原:为菊科植物牛蒡的干燥成熟果实。药性:辛、苦,寒。归肺、胃经。 功用主治:疏散风热,宣肺透疹,解毒利咽。用于风热感冒,咳嗽痰多,麻疹,风疹,咽喉肿痛,痒腮丹毒,痈肿疮毒。
枸杞子:基原:为茄科植物枸杞或宁夏枸杞的成熟果实。化学成份:枸杞子中含胡萝卜素3.39毫克%,硫胺素0.23毫克%,核黄素0.33毫克%,烟酸1.7毫克%,抗坏血酸3毫克%。尚分离出β-谷甾醇、亚油酸。日本产枸杞果实含玉蜀黍黄素、甜菜碱和一种硫胺素抑制物。果皮含酸浆果红素。药性:甘,平。归肝、肾经。功用主治:滋肾,润肺,补肝,明目。治肝肾阴亏,腰膝酸软,头晕,目眩,目昏多泪,虚劳咳嗽,消渴,遗精。
九子连环草:基原:为兰科虾脊兰属植物虾脊兰的全草或根茎。成分:新鲜根茎含吲哚类及其糖苷:虾脊兰苷A、B,二氢菲衍生物,β-吲哚葡萄糖苷,虾脊兰菲醇,琉球虾脊兰苷;吲哚类生物碱类:色胺酮,靛玉红等。药性:辛、微苦,微寒。功用主治:清热解毒,活血止痛。主治痈肿,咽喉肿痛,痔疮,风湿痹痛,跌打损伤。
实施例1风湿性关节炎祛风胜湿膏,取下述重量份的主要原料药制备而成(每份为40g):独活10份,丝棉木6份,红孩儿9份,葛根20份,川芎9份,薏米10份,川断9份,小过江龙8份,天南星(胆汁制)9份,古羊藤12份,牛蒡子15份,枸杞子20份,九子连环草10份。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐1.8kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入猪胆汁,每100kg天南星加胆汁250kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的7倍,先用大火煮至沸腾,后转小火煎煮1.4小时,第二次加水量为11味药材总重量的5.5倍,先用大火煮至沸腾,后转小火煎煮1.1小时,滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的1.8倍,加入乙醇,使乙醇量达50%,静置24 h,取上清液,浓缩至相对密度为1.05的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
本发明风湿性关节炎祛风胜湿膏的使用方法:使用时先将皮肤用温水清洗擦干,贴于患处,用手掌将膏药按摩,使其粘在皮肤上,一天换帖一次。
实施例2风湿性关节炎祛风胜湿膏,取下述重量份的主要原料药制备而成(每份为40g):独活20份,丝棉木12份,红孩儿12份,葛根30份,川芎16份,薏米20份,川断18份,小过江龙15份,天南星(胆汁制)12份,古羊藤16份,牛蒡子25份,枸杞子30份,九子连环草15份。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐2.5kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入猪胆汁,每100kg天南星加胆汁500kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的10倍,先用大火煮至沸腾,后转小火煎煮2小时,第二次加水量为11味药材总重量的8.5倍,先用大火煮至沸腾,后转小火煎煮1.6小时,滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.8倍,加入乙醇,使乙醇量达70%,静置24 h,取上清液,浓缩至相对密度为1.15的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
典型病例一:赵XX,女,45岁。4年余前无明显诱因出现双脚麻木、双踝关节肿胀,继之出现双手近端指关节肿痛,活动受限。于当地医院予以中药治疗,双手指关节肿痛缓解,但双脚麻木、肿胀无好转。2年前出现右膝关节酸痛、肿胀。检查:查RF 1752 IU/mL,CRP 38.5mg/L,血沉 100mm/h,血常规提示 HB 75g/L,MCV 69.6fL,MCHC 292g/L,血清铁 1.8umoL/L,ALB 28g/L。诊断为风湿性关节炎。服用强的松片等药物,均未见好转。使用本实施例所得风湿性关节炎祛风胜湿膏,先将皮肤用温水清洗擦干,贴于患处,用手掌将膏药按摩,使其粘在皮肤上,一天换帖一次。使用半个月,关节疼痛、肿胀等症状减轻。使用1个月,症状消失,痊愈。随访未复发。
实施例3风湿性关节炎祛风胜湿膏,取下述重量份的主要原料药制备而成(每份为40g):独活13份,丝棉木8份,红孩儿9.5份,葛根22份,川芎12份,薏米14份,川断11份,小过江龙10份,天南星(胆汁制)9.5份,古羊藤13份,牛蒡子19份,枸杞子22份,九子连环草11份。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐2.0kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入牛胆汁,每100kg天南星加胆汁300kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的8倍,先用大火煮至沸腾,后转小火煎煮1.5小时,第二次加水量为11味药材总重量的6.5倍,先用大火煮至沸腾,后转小火煎煮1.2小时,滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.2倍,加入乙醇,使乙醇量达55%,静置24 h,取上清液,浓缩至相对密度为1.08的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
典型病例二:李XX,男,36岁。一年前发现双手指红肿、发热,关节变形,手一遇凉时疼痛便加重。特别在冬季、夏季潮湿天气时疼痛就更厉害了。由于手指关节变形丧失劳动力,终日在家。去医院检查,诊断为风湿性关节炎。曾经用过贴膏药、针灸、推拿能暂时性的起到疏通血脉,活血通络的效果,但是止痛不治痛,膏药一旦停用,疼痛就会重新来袭。使用本实施例所得风湿性关节炎祛风胜湿膏,先将皮肤用温水清洗擦干,贴于患处,用手掌将膏药按摩,使其粘在皮肤上,一天换帖一次。使用10天后,疼痛减轻,有明显好转。使用半个月,关节轻度疼痛,肿胀不显。使用20天后,患者诸多关节疼痛消失,肿胀消退,活动自如,发热消失,舌质淡红,脉弦缓,病情达到临床治愈效果。随访未见复发。
实施例4风湿性关节炎祛风胜湿膏,取下述重量份的主要原料药制备而成(每份为40g):独活17份,丝棉木11份,红孩儿11份,葛根27份,川芎15份,薏米18份,川断15份,小过江龙13份,天南星(胆汁制)11份,古羊藤15份,牛蒡子22份,枸杞子26份,九子连环草13份。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐2.3kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入羊胆汁,每100kg天南星加胆汁450kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的9.5倍,先用大火煮至沸腾,后转小火煎煮1.8小时,第二次加水量为11味药材总重量的7.5倍,先用大火煮至沸腾,后转小火煎煮1.5小时,滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.6倍,加入乙醇,使乙醇量达65%,静置24 h,取上清液,浓缩至相对密度为1.13的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
典型病例三:刘XX,女,32岁。因天气炎热,空调温度过低受凉,次日觉咽痛、头痛、恶寒发热,鼻塞轻咳,周身关节酸状疼痛。10天后,肘、膝、腕、踝关节痹痛加剧,屈伸不利,但发热无恶寒。经当地医院诊断,给予消炎痛、强的松口服,青霉素静滴无效。要求服用中药,遂前来就诊。诊断:两膝及腕、踝关节红肿、欣热,身热而赤,汗出恶热,口干,舌红、苔黄腻,脉滑数。检查抗o 500u,血沉95mm/1h,诊断为风湿性关节炎。使用本实施例所得风湿性关节炎祛风胜湿膏,先将皮肤用温水清洗擦干,贴于患处,用手掌将膏药按摩,使其粘在皮肤上,一天换帖一次。使用15天,红肿、发热、疼痛症状明显减轻。使用25天,红肿消失,发热退去,疼痛消失,诸症消失。随访无复发。
实施例5风湿性关节炎祛风胜湿膏,取下述重量份的主要原料药制备而成(每份为40g):独活15份,丝棉木10份,红孩儿10份,葛根25份,川芎14份,薏米16份,川断14份,小过江龙12份,天南星(胆汁制)10.5份,古羊藤14份,牛蒡子20份,枸杞子24份,九子连环草12份。
上述风湿性关节炎祛风胜湿膏的制备方法是:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐2.2kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入牛胆汁,每100kg天南星加胆汁400kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的8.8倍,先用大火煮至沸腾,后转小火煎煮1.6小时,第二次加水量为11味药材总重量的7倍,先用大火煮至沸腾,后转小火煎煮1.4小时,滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积(按毫升计)为原生药重量(按克计)的2.4倍,加入乙醇,使乙醇量达60%,静置24 h,取上清液,浓缩至相对密度为1.1的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
试验例:为了验证本发明所得风湿性关节炎祛风胜湿膏(实施例5)的药效,我们进行了对比试验。2009年2月-2012年5月,在7所医院筛选242例风湿性关节炎患者,其中男性96例,女性146例,年龄24-71岁,平均年龄45岁,病程1-16年。随机分为两组,实验组和对照组(每组121人)。实验组男性48例,女性73例,年龄24-71岁,平均年龄45岁,病程1-16年。对照组男性48例,女性73例,年龄24-71岁,平均年龄45岁,病程1-16年。病例采取随机采集法,根据美国风湿病学1987年发布的风湿病诊断标准。实验组使用本发明所得产品,使用方法:先将皮肤用温水清洗擦干,贴于患处,用手掌将膏药按摩,使其粘在皮肤上,一天换帖一次。对照组使用常规治疗风湿性关节炎的药物(如布洛芬缓释胶囊、双氯芬酸钠肠溶片、吲哚美辛软膏、芬布芬片)。疗效标准:参照中华医学会风湿病会,1985年试行的疗效考核以及全国中西医结合风湿病学会疗效判定标准。治愈:临床症状全部消失,各关节部位活动如常,抗“O”和血沉在正常范围内,线摄片提示病变部位软组织炎症肿胀消失;显效:临床症状明显减轻,各关节活动功能基本恢复,抗“O”和血沉在正常范围内,线摄片提示软组织炎症肿胀消失;好转:临床症状有所减轻,各关节活动功能有所提高,抗“O”和血沉有所下降和缓解,线摄片提示软组织炎症肿胀大部消失;无效:经治疗后病情无好转者。总有效包括治愈和显效。治疗25天后,结果如表1所示。
表1:本发明所得风湿性关节炎祛风胜湿膏效果验证[例(%)]
治疗效果:在实验组的121例患者中,治愈84例,占69.42%;显效34例,占28.1%;好转2例,占1.65%;无效1例,占0.83%,总有效率达97.52%。效果明显优于对照组。
本发明由多味纯中草药精细配伍而成。方中独活祛风除湿,通痹止痛。丝棉木祛风除湿,活血通络,解毒止血。红孩儿清热解毒,散瘀消肿。葛根解肌退热,生津,透疹,升阳止泻。川芎活血行气,祛风止痛。薏米清热利湿,除风湿,利小便,益肺排脓,健脾胃,强筋骨。川断补肝肾,续筋骨,调血脉。小过江龙清热利湿,舒筋活络。天南星燥湿化痰,祛风定惊,消肿散结。古羊藤清热解毒,散瘀止痛。牛蒡子疏散风热,宣肺透疹,解毒利咽。枸杞子滋肾,润肺,补肝,明目。九子连环草清热解毒,活血止痛。诸药合用,具有祛风除湿、调肝益肾、舒筋活络、通痹止痛、强筋骨等功效,对于治疗风湿性关节炎效果显著。
最后应说明的是,实施例只是本发明最优的具体实施方式而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.风湿性关节炎祛风胜湿膏,其特征在于,取下述重量配比的主要原料药制备而成:独活10-20,丝棉木6-12,红孩儿9-12,葛根20-30,川芎9-16,薏米10-20,川断9-18,小过江龙8-15,天南星(胆汁制)9-12,古羊藤12-16,牛蒡子15-25,枸杞子20-30,九子连环草10-15。
2.如权利要求1所述的风湿性关节炎祛风胜湿膏,其特征在于,取下述重量配比的主要原料药制备而成:独活13-17,丝棉木8-11,红孩儿9.5-11,葛根22-27,川芎12-15,薏米14-18,川断11-15,小过江龙10-13,天南星(胆汁制)9.5-11,古羊藤13-15,牛蒡子19-22,枸杞子22-26,九子连环草11-13。
3.如权利要求1所述的风湿性关节炎祛风胜湿膏,其特征在于,取下述重量配比的主要原料药制备而成:独活15,丝棉木10,红孩儿10,葛根25,川芎14,薏米16,川断14,小过江龙12,天南星(胆汁制)10.5,古羊藤14,牛蒡子20,枸杞子24,九子连环草12。
4.如权利要求1~3任一所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤如下:
(1)取红孩儿,用盐水拌匀,每100kg红孩儿用食盐1.8-2.5kg,闷润至透,置热锅内,用文火加热,炒干,取出放凉,研成细粉;
(2)将天南星研粉,放入缸中,加入胆汁,每100kg天南星加胆汁250-500kg,至拌湿为度,日晒夜露,至无腥臭味为度,以手搓成团不散,晒干,研成细粉;
(3)将除红孩儿和天南星外的其余11味药材放入砂锅中,加水煎煮两次,第一次加水量为11味药材总重量的7-10倍(优选的,第一次加水量为11味药材总重量的8-9.5倍;更加优选的,第一次加水量为11味药材总重量的8.8倍),先用大火煮至沸腾,后转小火煎煮1.4-2小时(优选的,后转小火煎煮1.5-1.8小时;更加优选的,后转小火煎煮1.6小时),第二次加水量为11味药材总重量的5.5-8.5倍(优选的,第二次加水量为11味药材总重量的6.5-7.5倍;更加优选的,第二次加水量为11味药材总重量的7倍),先用大火煮至沸腾,后转小火煎煮1.1-1.6小时(优选的,后转小火煎煮1.2-1.5小时;更加优选的,后转小火煎煮1.4小时),滤出药液;
(4)将步骤(3)所得药液合并,用140目筛过滤,将滤液浓缩至体积为原生药重量的1.8-2.8倍,加入乙醇,使乙醇量达50%-70%,静置24 h,取上清液,浓缩至相对密度为1.05-1.15的流浸膏,然后加入步骤(1)和步骤(2)所得细粉,充分搅匀;
(5)取无纺布,裁剪成7cm×10cm的长方形,然后将其置于铝塑药袋内,加入步骤(4)所得,热压封口即得。
5.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(1)中每100kg红孩儿用食盐2.0-2.3kg(优选每100kg红孩儿用食盐2.2kg)。
6.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(2)中加入的胆汁为猪胆汁、牛胆汁或羊胆汁(优选加入的胆汁为牛胆汁)。
7.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(2)中每100kg天南星加胆汁300-450kg(优选每100kg天南星加胆汁400kg)。
8.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(4)中将滤液浓缩至体积为原生药重量的2.2-2.6倍(优选将滤液浓缩至体积为原生药重量的2.4倍)。
9.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(4)中使乙醇量达55%-65%(优选使乙醇量达60%)。
10.如权利要求4所述的风湿性关节炎祛风胜湿膏的制备方法,其特征在于,步骤(4)中浓缩至相对密度为1.08-1.13的流浸膏(优选浓缩至相对密度为1.1的流浸膏)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510003783.3A CN104491585A (zh) | 2015-01-06 | 2015-01-06 | 风湿性关节炎祛风胜湿膏及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510003783.3A CN104491585A (zh) | 2015-01-06 | 2015-01-06 | 风湿性关节炎祛风胜湿膏及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491585A true CN104491585A (zh) | 2015-04-08 |
Family
ID=52933099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510003783.3A Pending CN104491585A (zh) | 2015-01-06 | 2015-01-06 | 风湿性关节炎祛风胜湿膏及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491585A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105582204A (zh) * | 2015-09-09 | 2016-05-18 | 张苗 | 一种治疗斯蒂尔病的中药 |
CN105582528A (zh) * | 2016-02-24 | 2016-05-18 | 薛艳 | 一种小儿病毒性心肌炎的糖丸及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1180556A (zh) * | 1997-11-08 | 1998-05-06 | 葛洪 | 治疗风湿痛的药酒 |
CN101406606A (zh) * | 2008-11-20 | 2009-04-15 | 施昌钦 | 一种治疗风湿痹症、骨质增生、颈肩腰腿疼痛的膏药 |
-
2015
- 2015-01-06 CN CN201510003783.3A patent/CN104491585A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1180556A (zh) * | 1997-11-08 | 1998-05-06 | 葛洪 | 治疗风湿痛的药酒 |
CN101406606A (zh) * | 2008-11-20 | 2009-04-15 | 施昌钦 | 一种治疗风湿痹症、骨质增生、颈肩腰腿疼痛的膏药 |
Non-Patent Citations (1)
Title |
---|
高海涛等: "中医药治疗类风湿性关节炎研究进展", 《现代中医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105582204A (zh) * | 2015-09-09 | 2016-05-18 | 张苗 | 一种治疗斯蒂尔病的中药 |
CN105582528A (zh) * | 2016-02-24 | 2016-05-18 | 薛艳 | 一种小儿病毒性心肌炎的糖丸及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104208580A (zh) | 一种治疗风湿骨痛的中药组合物及其制备方法 | |
CN102210847A (zh) | 治疗痛经的药物组合物胶囊的制备方法及其应用 | |
CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
CN104606352A (zh) | 复方骨结核丸 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN102078569B (zh) | 一种治疗肝癌的中药制剂及其制备方法 | |
CN101011544A (zh) | 痛风速康颗粒(胶囊)及其制作工艺 | |
CN104826036A (zh) | 一种治疗乳腺增生的复合中药组合物及制备方法 | |
CN101537159B (zh) | 一种中药组合物及其制备方法和应用 | |
CN105125807A (zh) | 一种治疗青春期多囊卵巢综合征的中药组合物 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN104491585A (zh) | 风湿性关节炎祛风胜湿膏及制备方法 | |
CN102178781A (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN104645232A (zh) | 一种治疗双曲综合征的中药复合组合物及其制备方法和应用 | |
CN104523846A (zh) | 风湿性关节炎舒筋活络膏及制备方法 | |
CN104524494A (zh) | 一种中药组合物 | |
CN104069443A (zh) | 一种治疗急性化脓性骨髓炎的中药及制备方法 | |
CN106267028A (zh) | 一种治疗肺炎的中药组合物及其制备方法 | |
CN105362682A (zh) | 一种治疗月经过少的外用药物 | |
CN105079721A (zh) | 一种治疗骨关节炎的中药组合物及其制备方法 | |
CN104758701A (zh) | 一种胃结石碎石后护理治疗的药物及其制备方法 | |
CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
CN104689067A (zh) | 一种治疗性早熟的中药组合物及其应用 | |
CN103800744A (zh) | 一种全部以药食同源药材制备的祛痘组合物 | |
CN101991790A (zh) | 治疗假性糖尿病的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Ruyi Lane 678000 Yunnan province Baoshan City Longyang District No. 64 Building No. 6 5-202 Applicant after: Wang Guohui Address before: The Central Party's home town of Xiaotun Village Garden District Ji'nan City, Shandong province 250000 Applicant before: Wang Guohui |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |